Spinal cord stimulation for predominant low back pain in failed back surgery syndrome: study protocol for an international multicenter randomized controlled trial (PROMISE study)

Philippe Rigoard, Mehul J Desai, Richard B North, Rod S Taylor, Lieven Annemans, Christine Greening, Ye Tan, Carine Van den Abeele, Jane Shipley, Krishna Kumar, Philippe Rigoard, Mehul J Desai, Richard B North, Rod S Taylor, Lieven Annemans, Christine Greening, Ye Tan, Carine Van den Abeele, Jane Shipley, Krishna Kumar

Abstract

Background: Although results of case series support the use of spinal cord stimulation in failed back surgery syndrome patients with predominant low back pain, no confirmatory randomized controlled trial has been undertaken in this patient group to date. PROMISE is a multicenter, prospective, randomized, open-label, parallel-group study designed to compare the clinical effectiveness of spinal cord stimulation plus optimal medical management with optimal medical management alone in patients with failed back surgery syndrome and predominant low back pain.

Method/design: Patients will be recruited in approximately 30 centers across Canada, Europe, and the United States. Eligible patients with low back pain exceeding leg pain and an average Numeric Pain Rating Scale score ≥5 for low back pain will be randomized 1:1 to spinal cord stimulation plus optimal medical management or to optimal medical management alone. The investigators will tailor individual optimal medical management treatment plans to their patients. Excluded from study treatments are intrathecal drug delivery, peripheral nerve stimulation, back surgery related to the original back pain complaint, and experimental therapies. Patients randomized to the spinal cord stimulation group will undergo trial stimulation, and if they achieve adequate low back pain relief a neurostimulation system using the Specify® 5-6-5 multi-column lead (Medtronic Inc., Minneapolis, MN, USA) will be implanted to capture low back pain preferentially in these patients. Outcome assessment will occur at baseline (pre-randomization) and at 1, 3, 6, 9, 12, 18, and 24 months post randomization. After the 6-month visit, patients can change treatment to that received by the other randomized group. The primary outcome is the proportion of patients with ≥50% reduction in low back pain at the 6-month visit. Additional outcomes include changes in low back and leg pain, functional disability, health-related quality of life, return to work, healthcare utilization including medication usage, and patient satisfaction. Data on adverse events will be collected. The primary analysis will follow the intention-to-treat principle. Healthcare use data will be used to assess costs and long-term cost-effectiveness.

Discussion: Recruitment began in January 2013 and will continue until 2016.

Trial registration: Clinicaltrials.gov: NCT01697358 (http://www.clinicaltrials.gov).

Figures

Figure 1
Figure 1
PROMISE trial patient flow. *Therapy change may occur at any time post 6-month visit. OMM, optimal medical management; SCS, spinal cord stimulation.

References

    1. Macrae WA. Chronic pain after surgery. Br J Anaesth. 2001;87:88–98. doi: 10.1093/bja/87.1.88.
    1. Taylor RS, Taylor RJ. The economics of failed back surgery syndrome. Br J Pain. 2012;6:140–141. doi: 10.1177/2049463712470781.
    1. Turk DC, Okifuji A. In: Bonica’s Management of Pain. 3. Loeser JD, editor. Philadelphia: Lippincott Williams & Wilkins; 2001. Pain terms and taxonomies of pain; pp. 17–25.
    1. Manca A, Eldabe S, Buchser E, Kumar K, Taylor RS. Relationship between health-related quality of life, pain, and functional disability in neuropathic pain: patients with failed back surgery syndrome. Value Health. 2010;13:95–102. doi: 10.1111/j.1524-4733.2009.00588.x.
    1. Doth A, Hansson PS, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149:338–344. doi: 10.1016/j.pain.2010.02.034.
    1. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, North RB. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132:179–188. doi: 10.1016/j.pain.2007.07.028.
    1. Taylor RS, Ryan J, O'Donnell R, Eldabe S, Kumar K, North RB. The cost-effectiveness of spinal cord stimulation in the treatment of failed back surgery syndrome. Clin J Pain. 2010;26:463–469. doi: 10.1097/AJP.0b013e3181daccec.
    1. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, North RB. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery. 2008;63:762–770. doi: 10.1227/01.NEU.0000325731.46702.D9.
    1. North RB, Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery. 2005;56:98–106.
    1. North RB, Shipley J, Taylor RS. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurg. 2007;61:361–368. doi: 10.1227/01.NEU.0000255522.42579.EA.
    1. Law JD. Targeting a spinal stimulator to treat the 'failed back surgery syndrome’. Appl Neurophysiol. 1987;50:437–438.
    1. North R, Shipley J, Prager J, Barolat G, Barulich M, Bedder M, Calodney A, Daniels A, Deer T, DeLeon O, Drees S, Fautdch M, Fehrenbach W, Hernandez J, Kloth D, Krames ES, Lubenow T, North R, Osenbach R, Panchal SJ, Sitzman T, Staats P, Tremmel J, Wetzel T. Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain. Pain Med. 2007;8(Suppl 4):S200–S275.
    1. Oakley JC. Spinal cord stimulation in axial low back pain: solving the dilemma. Pain Med. 2006;7:C58–C63.
    1. North RB, Kidd DH, Olin JC, Sieracki JN. Spinal cord stimulation electrode design: a prospective, randomized, controlled trial comparing percutaneous and laminectomy electrodes – part I: technical outcomes. Neurosurgery. 2002;51:381–389.
    1. North RB, Kidd DH, Olin J, Sieracki JM, Farrokhi F, Petrucci L, Cutchis PN. Spinal cord stimulation for axial low back pain: a prospective, controlled trial comparing dual with single percutaneous electrodes. Spine. 2005;30:1412–1418. doi: 10.1097/01.brs.0000166502.05449.a8.
    1. North RB, Kidd DH, Olin J, Sieracki JN, Petrucci L. Spinal cord stimulation for axial low back pain: a prospective, controlled trial comparing 16-contact insulated electrode arrays with 4-contact percutaneous electrodes. Neuromodulation. 2006;9:56–67. doi: 10.1111/j.1525-1403.2006.00043.x.
    1. Rigoard P, Delmotte A, Dʼhoutaud S, Misbert L, Diallo B, Roy-Moreau A, Durand S, Royoux S, Giot JP, Bataille B. Back pain: a real target for spinal cord stimulation? Neurosurgery. 2012;70:574–585. doi: 10.1227/NEU.0b013e318236a57c.
    1. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, Brandenburg N, Burke LB, Cella D, Chandler J, Cowan P, Dimitrova R, Dionne R, Hertz S, Jadad AR, Katz NP, Kehlet H, Kramer LD, Manning DC, McCormick C, McDermott MP, McQuay HJ, Patel S, Porter L, Quessy S, Rappaport BA. et al.Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105–121. doi: 10.1016/j.jpain.2007.09.005.
    1. Fairbank J, Pynsent P. The Oswestry disability index. Spine. 2000;25:2940–2953. doi: 10.1097/00007632-200011150-00017.
    1. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263. doi: 10.1097/00005650-199303000-00006.
    1. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.
    1. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5 L) Qual Life Res. 2011;20:1727–1736. doi: 10.1007/s11136-011-9903-x.
    1. Buysse DJ, Reynolds CF 3rd, Monk TH, Hoch CC, Yeager AL, Kupfer DJ. Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI) Sleep. 1991;14:331–338.
    1. Manca A, Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, Taylor RJ, Goeree R, Sculpher MJ. Quality of life, resource consumption and costs of spinal cord simulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial) Eur J Pain. 2008;12:1047–1058. doi: 10.1016/j.ejpain.2008.01.014.
    1. Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004;27:26–35. doi: 10.1016/j.jmpt.2003.11.003.
    1. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) Pain. 2005;114:29–36. doi: 10.1016/j.pain.2004.12.010.
    1. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials. 1986;7:267–275. doi: 10.1016/0197-2456(86)90034-6.
    1. Moore RA, Straube S, Eccleston C, Derry S, Aldington D, Wiffen P, Bell RF, Hamunen K, Phillips C, McQuay H. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain. 2012;153:265–268. doi: 10.1016/j.pain.2011.10.004.
    1. Mauskopf JA, Paul JE, Grant DM, Stergachis A. The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics. 1998;13:277–288. doi: 10.2165/00019053-199813030-00002.
    1. International Organization for Standardization. .
    1. Taylor RS, Buscher E, Van Buyten J-P. Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors. Spine. 2005;30:152–160.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다